Your browser doesn't support javascript.
loading
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Palmer, Suetonia C; Tendal, Britta; Mustafa, Reem A; Vandvik, Per Olav; Li, Sheyu; Hao, Qiukui; Tunnicliffe, David; Ruospo, Marinella; Natale, Patrizia; Saglimbene, Valeria; Nicolucci, Antonio; Johnson, David W; Tonelli, Marcello; Rossi, Maria Chiara; Badve, Sunil V; Cho, Yeoungjee; Nadeau-Fredette, Annie-Claire; Burke, Michael; Faruque, Labib I; Lloyd, Anita; Ahmad, Nasreen; Liu, Yuanchen; Tiv, Sophanny; Millard, Tanya; Gagliardi, Lucia; Kolanu, Nithin; Barmanray, Rahul D; McMorrow, Rita; Raygoza Cortez, Ana Karina; White, Heath; Chen, Xiangyang; Zhou, Xu; Liu, Jiali; Rodríguez, Andrea Flores; González-Colmenero, Alejandro Díaz; Wang, Yang; Li, Ling; Sutanto, Surya; Solis, Ricardo Cesar; Díaz González-Colmenero, Fernando; Rodriguez-Gutierrez, René; Walsh, Michael; Guyatt, Gordon; Strippoli, Giovanni F M.
Afiliación
  • Palmer SC; Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Tendal B; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Mustafa RA; Department of Internal Medicine, Division of Nephrology and Hypertension, University of Kansas, Kansas City, KS, USA.
  • Vandvik PO; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
  • Li S; Institute of Health and Society, University of Oslo, Oslo, Norway.
  • Hao Q; Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
  • Tunnicliffe D; Division of Population Health and Genomics, Ninewells Hospital, University of Dundee, Dundee, UK.
  • Ruospo M; Centre for Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
  • Natale P; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
  • Saglimbene V; Department of Emergency and Organ Transplantation, University of Bari, Piazza Giulio CESARE, 70124 Bari, Italy.
  • Nicolucci A; Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
  • Johnson DW; Department of Emergency and Organ Transplantation, University of Bari, Piazza Giulio CESARE, 70124 Bari, Italy.
  • Tonelli M; Department of Emergency and Organ Transplantation, University of Bari, Piazza Giulio CESARE, 70124 Bari, Italy.
  • Rossi MC; Centre for Outcomes Research and Clinical Epidemiology (CORESEARCH), Pescara, Italy.
  • Badve SV; Department of Nephrology, Division of Medicine, University of Queensland at Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
  • Cho Y; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Nadeau-Fredette AC; Centre for Outcomes Research and Clinical Epidemiology (CORESEARCH), Pescara, Italy.
  • Burke M; George Institute for Global Health, Sydney, NSW, Australia.
  • Faruque LI; Department of Nephrology, Division of Medicine, University of Queensland at Princess Alexandra Hospital, Woolloongabba, QLD, Australia.
  • Lloyd A; Division of Nephrology, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
  • Ahmad N; Mater Private Clinic, Brisbane, QLD, Australia.
  • Liu Y; Department of Nephrology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
  • Tiv S; Department of Nephrology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
  • Millard T; Department of Nephrology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
  • Gagliardi L; Department of Nephrology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
  • Kolanu N; Department of Nephrology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
  • Barmanray RD; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • McMorrow R; Endocrine and Diabetes Unit, Queen Elizabeth Hospital, Woodville, SA, Australia.
  • Raygoza Cortez AK; Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.
  • White H; Garvan Institute of Medical Research, Sydney, NSW, Australia.
  • Chen X; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
  • Zhou X; Department of General Practice and Primary Health Care, University of Melbourne, Melbourne, VIC, Australia.
  • Liu J; Plataforma INVEST Medicina UANL-KER Unit Mayo Clinic (KER Unit Mexico), Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Rodríguez AF; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • González-Colmenero AD; Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.
  • Wang Y; Evidence-based Medicine Research Centre, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
  • Li L; Chinese Evidence-based Medicine Centre, Cochrane China Centre.
  • Sutanto S; Plataforma INVEST Medicina UANL-KER Unit Mayo Clinic (KER Unit Mexico), Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Solis RC; Plataforma INVEST Medicina UANL-KER Unit Mayo Clinic (KER Unit Mexico), Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Díaz González-Colmenero F; West China School of Medicine, Sichuan University, Chengdu, China.
  • Rodriguez-Gutierrez R; Chinese Evidence-based Medicine Centre, Cochrane China Centre.
  • Walsh M; Faculty of Medicine and Health, Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.
  • Guyatt G; Plataforma INVEST Medicina UANL-KER Unit Mayo Clinic (KER Unit Mexico), Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Strippoli GFM; Plataforma INVEST Medicina UANL-KER Unit Mayo Clinic (KER Unit Mexico), Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
BMJ ; 372: m4573, 2021 01 13.
Article en En | MEDLINE | ID: mdl-33441402
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mortalidad / Diabetes Mellitus Tipo 2 / Receptor del Péptido 1 Similar al Glucagón / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hipoglucemiantes Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: BMJ Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mortalidad / Diabetes Mellitus Tipo 2 / Receptor del Péptido 1 Similar al Glucagón / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Hipoglucemiantes Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: BMJ Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Reino Unido